ENTRY       D03232                      Drug
NAME        Epoetin beta (USAN/INN);
            Epoetin beta (genetical recombination) (JP18);
            Marogen (TN)
FORMULA     C809H1301N229O240S5
EXACT_MASS  18224.5242
MOL_WEIGHT  18235.7015
REMARK      Therapeutic category: 3999
            ATC code: B03XA01
            Chemical structure group: DG00177
            Product (DG00177): D03231<JP/US> D03232<JP>
EFFICACY    Anti-anemic, Hematinic, Erythropoietin receptor agonist
TARGET      EPOR [HSA:2057] [KO:K05079]
  PATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction
            hsa04630(2057)  JAK-STAT signaling pathway
            hsa04640(2057)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03X OTHER ANTIANEMIC PREPARATIONS
                B03XA Other antianemic preparations
                 B03XA01 Erythropoietin
                  D03232  Epoetin beta (USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D03232  Epoetin beta (USAN/INN); Epoetin beta (genetical recombination) (JP18)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                EPOR
                 D03232  Epoetin beta (USAN/INN) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03232  Epoetin beta (genetical recombination)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03232
DBLINKS     CAS: 122312-54-3
            PubChem: 17397385
///
